BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3370859)

  • 1. Severe cerebral damage in ornithine transcarbamylase deficiency.
    Dolman CL; Clasen RA; Dorovini-Zis K
    Clin Neuropathol; 1988; 7(1):10-5. PubMed ID: 3370859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperammonemia due to ornithine transcarbamylase deficiency--a cause of lethal metabolic crisis during the newborn period and infancy (author's transl)].
    Schuchmann L; Colombo JP; Fischer H
    Klin Padiatr; 1980 May; 192(3):281-5. PubMed ID: 7191930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid.
    Thakur V; Rupar CA; Ramsay DA; Singh R; Fraser DD
    Pediatr Crit Care Med; 2006 May; 7(3):273-6. PubMed ID: 16575347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the cause and treatment of hyperammonemia in females with ornithine transcarbamylase deficiency.
    Glasgow AM; Kraegel JH; Schulman JD
    Pediatrics; 1978 Jul; 62(1):30-7. PubMed ID: 683780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
    Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
    N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperammonemia in the newborn through ornithine transcarbamylase deficiency (author's transl)].
    Plöchl E; Hilbe W; Bachmann C
    Padiatr Padol; 1981; 16(2):179-88. PubMed ID: 7243329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel two-nucleotide deletion in the ornithine transcarbamylase gene causing fatal hyperammonia in early pregnancy.
    Schimanski U; Krieger D; Horn M; Stremmel W; Wermuth B; Theilmann L
    Hepatology; 1996 Dec; 24(6):1413-5. PubMed ID: 8938172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance.
    Badizadegan K; Perez-Atayde AR
    Hepatology; 1997 Aug; 26(2):365-73. PubMed ID: 9252147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
    Pridmore CL; Clarke JT; Blaser S
    J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An anesthetic experience with a patient with ornithine transcarbamylase deficiency].
    Hirota K; Shiga T; Kimura K; Matsuki A; Oyama T
    Masui; 1989 Jan; 38(1):98-101. PubMed ID: 2709615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abrupt onset and rapid deterioration in the course of congenital ornithine transcarbamylase deficiency: a case report].
    Fukuizumi H; Kudo J; Shimamura R; Fujimoto K; Ishibashi H; Niho Y; Taniyama T; Kumashiro T
    Fukuoka Igaku Zasshi; 1990 Jul; 81(7):247-53. PubMed ID: 2210591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapy of hyperammonemia due to ornithine transcarbamylase defiency in a male neonate.
    Snyderman SE; Sansaricq C; Phansalkar SV; Schacht RC; Norton PM
    Pediatrics; 1975 Jul; 56(1):65-73. PubMed ID: 1153252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency.
    McBride KL; Miller G; Carter S; Karpen S; Goss J; Lee B
    Pediatrics; 2004 Oct; 114(4):e523-6. PubMed ID: 15466081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.
    Tuchman M; Yudkoff M
    Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual biochemical and clinical features in a girl with ornithine transcarbamylase deficiency.
    Lacey DJ; Duffner PK; Cohen ME; Mosovich L
    Pediatr Neurol; 1986; 2(1):51-3. PubMed ID: 3508674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotic demyelination syndrome as a consequence of treating hyperammonemia in a patient with ornithine transcarbamylase deficiency.
    Cardenas JF; Bodensteiner JB
    J Child Neurol; 2009 Jul; 24(7):884-6. PubMed ID: 19225137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anesthetic management of a patient with ornithine transcarbamylase deficiency associated with hyperammonemia (author's transl)].
    Yasuoka M; Kokubo S
    Masui; 1978 May; 27(5):526-32. PubMed ID: 660908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neonatal hyperammonemia due to ornithine transcarbamylase deficiency (author's transl)].
    del Valle JA; Urbón A; García MJ; Cuadrado P; Ugarte M
    An Esp Pediatr; 1982 May; 16(5):416-20. PubMed ID: 7114619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity.
    Hoshide R; Matsuura T; Sagara Y; Kubo T; Shimadzu M; Endo F; Matsuda I
    Am J Med Genet; 1996 Aug; 64(3):459-64. PubMed ID: 8862622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.